Paper

Tree Display

AceDB Schema

XML Display

Feedback

Paper Report for: Koide_2018_Cancer.Chemother.Pharmacol_81_1121

Reference

Title: Acceleration of carboxylesterase-mediated activation of irinotecan to SN-38 by serum from patients with end-stage kidney disease
Koide H, Tsujimoto M, Katsube Y, Ochiai M, Hojo A, Furukubo T, Izumi S, Yamakawa T, Shima D and Nishiguchi K <1 more author(s)>
Ref: Cancer Chemother Pharmacol, 81:1121, 2018 : PubMed

        



Related information

Inhibitor | SN-38,


Citations formats

Koide H, Tsujimoto M, Katsube Y, Ochiai M, Hojo A, Furukubo T, Izumi S, Yamakawa T, Shima D, Minegaki T, Nishiguchi K (2018)
Acceleration of carboxylesterase-mediated activation of irinotecan to SN-38 by serum from patients with end-stage kidney disease
Cancer Chemother Pharmacol 81: 1121-1128

Koide H, Tsujimoto M, Katsube Y, Ochiai M, Hojo A, Furukubo T, Izumi S, Yamakawa T, Shima D, Minegaki T, Nishiguchi K (2018)
Cancer Chemother Pharmacol 81: 1121-1128



Send your questions or comments to :
Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.
Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.
For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page
webmaster

Acknowledgements and disclaimer